SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001341004-10-000639
Filing Date
2010-04-06
Accepted
2010-04-06 08:03:18
Documents
11
Period of Report
2010-04-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8K form8k.htm 8-K 67702
2 US PLAN ex10-1.htm EX-10.1 107861
3 UK PLAN ex10-2.htm EX-10.2 164774
4 RACHMAN LETTER ex10-3.htm EX-10.3 23920
5 EPSTEIN LETTER ex10-4.htm EX-10.4 30372
6 EPSTEIN LETTER ex10-5.htm EX-10.5 19908
7 DAVIES LETTER ex10-6.htm EX-10.6 13613
8 DAVIES LETTER ex10-7.htm EX-10.7 25972
9 PRESS RELEASE ex99-1.htm EX-99.1 11584
10 CONVERSION NOTICE ex99-2.htm EX-99.2 30465
11 ex99-21.jpg GRAPHIC 8275
  Complete submission text file 0001341004-10-000639.txt   509533
Mailing Address 41 PINELAWN ROAD MELVILLE NY 11747
Business Address 41 PINELAWN ROAD MELVILLE NY 11747 631-962-2000
OSI PHARMACEUTICALS INC (Filer) CIK: 0000729922 (see all company filings)

IRS No.: 133159796 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-15190 | Film No.: 10733170
SIC: 2835 In Vitro & In Vivo Diagnostic Substances